Market revenue in 2022 | USD 222.0 million |
Market revenue in 2030 | USD 489.0 million |
Growth rate | 10.4% (CAGR from 2022 to 2030) |
Largest segment | 13-24 weeks |
Fastest growing segment | 0-12 weeks |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | 0-12 weeks, 13-24 weeks, 25-36 weeks |
Key market players worldwide | CooperSurgical, Natera Inc, Eurofins Scientific SE, Illumina Inc, Centogene NV Ordinary Shares, MedGenome, Myriad Genetics Inc, Roche Holding AG, Qiagen NV, Labcorp Holdings Inc, Quest Diagnostics Inc, Biora Therapeutics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non invasive prenatal testing market will help companies and investors design strategic landscapes.
13-24 weeks was the largest segment with a revenue share of 51.13% in 2022. Horizon Databook has segmented the Canada non invasive prenatal testing market based on 0-12 weeks, 13-24 weeks, 25-36 weeks covering the revenue growth of each sub-segment from 2018 to 2030.
Canada is expected to witness significant growth in the non-invasive prenatal testing market owing to the rising adoption of noninvasive techniques to diagnose chromosomal abnormalities. It has been stated that in Ontario, the Ministry of Health and Long-Term Care (MOHLTC) approves NIPT for certain circumstances and can receive out-of-country funding.
Furthermore, data is emerging that shows NIPT platforms can perform better than other aneuploidy screens for average-risk population. The Society of Obstetricians and Gynaeco logists of Canada (SOGC) guidelines warn that the usage of NIPT as first-line screening is expensive.
In addition, women who do not qualify for funding out of country by MOHLTC need to pay for NIPT out of pocket. The price of prenatal tests varies from USD 795- to USD 1,200 based on the company. The tests are only available in Ontario with government funding and women from other regions have to access them either using private insurance or out ofpocket expenses.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada non invasive prenatal testing market , including forecasts for subscribers. This country databook contains high-level insights into Canada non invasive prenatal testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account